Compare LVS & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LVS | PHG |
|---|---|---|
| Founded | 1988 | 1891 |
| Country | United States | Netherlands |
| Employees | N/A | 64317 |
| Industry | Hotels/Resorts | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.2B | 26.5B |
| IPO Year | 2004 | N/A |
| Metric | LVS | PHG |
|---|---|---|
| Price | $47.76 | $25.02 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $69.21 | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 858.7K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | 2.23% | ★ 3.21% |
| EPS Growth | ★ 19.90 | N/A |
| EPS | ★ 1.38 | N/A |
| Revenue | ★ $13,017,000,000.00 | N/A |
| Revenue This Year | $7.24 | $2.93 |
| Revenue Next Year | $4.49 | $4.49 |
| P/E Ratio | $54.21 | ★ $28.46 |
| Revenue Growth | ★ 15.22 | N/A |
| 52 Week Low | $44.21 | $25.10 |
| 52 Week High | $70.45 | $33.44 |
| Indicator | LVS | PHG |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 40.59 |
| Support Level | $44.22 | $25.28 |
| Resistance Level | $54.81 | $27.50 |
| Average True Range (ATR) | 1.17 | 0.50 |
| MACD | 0.33 | -0.16 |
| Stochastic Oscillator | 95.79 | 10.05 |
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.